Evidence map›Paper›PMID 31004482›Full record

ArticleEndocrinology2019

Prolactin Receptor Signaling Regulates a Pregnancy-Specific Transcriptional Program in Mouse Islets.

Mark E Pepin, Hayden H Bickerton, Maigen Bethea, Chad S Hunter, Adam R Wende, Ronadip R Banerjee

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Beta-cell compensation and gestational diabetes.The Journal of biological chemistry · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. TPH1 and 5-HTCancers · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mark E PepinDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
Hayden H BickertonDivision of Endocrinology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
Maigen BetheaDivision of Endocrinology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
Chad S HunterDivision of Endocrinology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
Adam R WendeDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
Ronadip R BanerjeeDivision of Endocrinology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
University of Alabama at Birmingham · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
Training Program in Cell, Molecular, and Developmental BiologyT32GM008111 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 1985 to 2022
$5.4M
Revealing LIM Domain Transcriptional Complexes that establish and maintain Beta Cell MassR01DK111483 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Chad S Hunter · 2017 to 2026
$3.4M
Glucose-Mediated Remodeling of Cardiac DNA MethylationR01HL133011 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WENDE, ADAM RAYMOND · 2017 to 2020
$1.5M
The role of Lhx1 in pancreatic beta cell development and functionF31DK111181 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JENKINS, MAIGEN MICHELLE BETHEA · 2017 to 2020
$146k
GADD45B and Metabolic Memory in Diabetic Heart FailureF30HL137240 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PEPIN, MARK EMILE · 2018 to 2019
$83k
NHLBI NIH HHS F30 HL137240NHLBI NIH HHS R01 HL133011NIDDK NIH HHS F31 DK111181NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK111483
6 · The paper itself

Abstract

Pancreatic β-cells undergo profound hyperplasia during pregnancy to maintain maternal euglycemia. Failure to reprogram β-cells into a more replicative state has been found to underlie susceptibility to gestational diabetes mellitus (GDM). We recently identified a requirement for prolactin receptor (PRLR) signaling in the metabolic adaptations to pregnancy, where β-cell-specific PRLR knockout (βPRLRKO) mice exhibit a metabolic phenotype consistent with GDM. However, the underlying transcriptional program that is responsible for the PRLR-dependent metabolic adaptations during gestation remains incompletely understood. To identify PRLR signaling gene regulatory networks and target genes within β-cells during pregnancy, we performed a transcriptomic analysis of pancreatic islets isolated from either βPRLRKO mice or littermate controls in late gestation. Gene set enrichment analysis identified forkhead box protein M1 and polycomb repressor complex 2 subunits, Suz12 and enhancer of zeste homolog 2 (Ezh2), as novel candidate regulators of PRLR-dependent β-cell adaptation. Gene ontology term pathway enrichment revealed both established and novel PRLR signaling target genes that together promote a state of increased cellular metabolism and/or proliferation. In contrast to the requirement for β-cell PRLR signaling in maintaining euglycemia during pregnancy, PRLR target genes were not induced following high-fat diet feeding. Collectively, the current study expands our understanding of which transcriptional regulators and networks mediate gene expression required for islet adaptation during pregnancy. The current work also supports the presence of pregnancy-specific adaptive mechanisms distinct from those activated by nutritional stress.

Indexed as

Gene Expression RegulationAnimalsCell LineCell Line, TumorCell ProliferationDiabetes, GestationalEnhancer of Zeste Homolog 2 ProteinFemaleGene Expression ProfilingGene OntologyGene Regulatory NetworksInsulin-Secreting CellsMice, Inbred C57BLMice, KnockoutPolycomb Repressive Complex 2PregnancyEnhancer of Zeste Homolog 2 ProteinPolycomb Repressive Complex 2Receptors, ProlactinSuz12 protein, mouse

Identifiers

PMID31004482
PMCPMC6475113
OpenAlexW2901313602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.